19 June 2013
Keywords: gsk, requip, fares, well, vs, schwarz, neupro
Article | 17 April 2006
UK pharmaceutical major GlaxoSmithKline says that its dopamine agonist ReQuip (ropinirole) was superior to Germany-based Shwarz Pharma's
rotigotine, in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2006
27 February 2006
18 June 2013
© 2013 thepharmaletter.com